Related Experiment Video

Updated: Jun 13, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

The role of HMGB1/RAGE in inflammatory cardiomyopathy

Hans C Volz1, Ziya Kaya, Hugo A Katus

  • 1Department of Medicine III, University of Heidelberg, Heidelberg, Germany.

Seminars in Thrombosis and Hemostasis
|April 24, 2010
PubMed

Insights

Inflammation drives heart failure progression. High-mobility group box-1 (HMGB1) and its receptor RAGE are key players in cardiac injury and remodeling, offering new therapeutic targets.

Area of Science:

  • Cardiology
  • Immunology
  • Molecular Biology

Background:

  • Heart failure is a growing health concern with high morbidity and mortality.
  • While causes like cardiomyopathies are known, progression to heart failure and adverse remodeling remain unclear.
  • Inflammatory mechanisms are increasingly implicated in heart failure progression.

Purpose of the Study:

  • To investigate the role of High-mobility group box-1 (HMGB1) and its receptor for advanced glycation end-product (RAGE) in cardiac injury and heart failure.
  • To explore HMGB1-RAGE pathway's involvement in ischemia/reperfusion (I/R) injury and post-myocardial infarction remodeling in diabetes.

Main Methods:

  • Demonstrated the role of HMGB1 and RAGE in early and late complications of cardiac I/R injury.
  • Investigated HMGB1 activation in enhanced post-myocardial infarction remodeling in type 1 diabetes mellitus.

Main Results:

  • HMGB1 and RAGE play a significant role in the pathogenesis of cardiac I/R injury complications.
  • HMGB1 activation partially mediates enhanced ventricular remodeling after myocardial infarction in type 1 diabetes.
  • The HMGB1-RAGE interaction is proposed as a critical initiator and sustainer of inflammation in inflammatory cardiomyopathy.

Conclusions:

  • The HMGB1-RAGE axis is a key inflammatory pathway contributing to heart failure development.
  • Targeting HMGB1 offers a potential novel therapeutic strategy for inflammatory cardiomyopathy and heart failure.

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...